EAM Investors’s Axonics, Inc. Common Stock AXNX Stock Holding History

EAM Investors’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-23,934	Closed	-$1.69M	–	355
2022 Q3	$1.69M	Buy	+23,934	New	+$1.65M	0.37%	117
2021 Q4	–	Sell	-27,094	Closed	-$1.76M	–	400
2021 Q3	$1.76M	Buy	+27,094	New	+$1.85M	0.3%	156
2020 Q4	–	Sell	-29,127	Closed	-$1.49M	–	405
2020 Q3	$1.49M	Buy	+29,127	New	+$1.22M	0.35%	108
2019 Q4	–	Sell	-82,757	Closed	-$2.23M	–	330
2019 Q3	$2.23M	Sell	82,757 -528	-0.6%	-$18.4K	0.59%	41
2019 Q2	$3.41M	Buy	83,285 +35,292	+74%	+$992K	0.83%	15
2019 Q1	$1.15M	Buy	+47,993	New	+$871K	0.28%	162

Other funds holding AXNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

HRCM

Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

EAM Investors's AXNX Position: Q4 2022 in Review

EAM Investors sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2022, closing a stake of 23,934 shares — an estimated $1.69M sold.

EAM Investors first reported a position in AXNX in Q1 2019 and held it in 6 quarters. The position peaked at $3.41M in Q2 2019. 235 funds tracked by Wall St. Rank hold AXNX as of Q4 2022.

EAM Investors reported no remaining Axonics, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
EAM Investors sold 23,934 Axonics, Inc. Common Stock shares in Q4 2022, an estimated $1.69M.
EAM Investors first reported a position in Axonics, Inc. Common Stock in Q1 2019 and held it in 6 quarters.
EAM Investors's Axonics, Inc. Common Stock position peaked at $3.41M in Q2 2019.
235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2022.

Based on EAM Investors's 13F filing for Q4 2022, filed 14 Feb 2023.